Tadalafilum
This medicine should always be taken exactly as described in this patient leaflet or as directed by your doctor or pharmacist.
Tadalafil APTEO MED is used to treat adult men with erectile dysfunction. This is a condition where a man cannot achieve or maintain an erection sufficient for sexual intercourse. It has been shown that tadalafil significantly improves the ability to achieve an erection sufficient for sexual intercourse.
Tadalafil APTEO MED contains the active substance tadalafil, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors. After sexual stimulation, Tadalafil APTEO MED helps to widen the blood vessels in the penis, allowing blood to flow into the penis, leading to an erection. As a result, there is an improvement in erection. Tadalafil APTEO MED does not help patients who do not have erectile dysfunction.
It is important to be aware that Tadalafil APTEO MED does not work in the absence of sexual stimulation. The patient and his partner should arrange foreplay, just as if the patient were not taking erectile dysfunction medication.
Before starting to take Tadalafil APTEO MED, the patient should use the diagnostic tool (questionnaire) attached to the packaging. In case of any doubts, they should discuss this with their doctor or pharmacist.
The patient should remember that sexual activity is associated with a risk for patients with heart disease, as it puts an additional strain on the heart. If the patient has heart problems, they should inform their doctor or pharmacist.
Before taking the medicine, the patient should inform their doctor or pharmacist if they have any of the following conditions:
It is not known if Tadalafil APTEO MED is effective in patients:
If the patient experiences sudden worsening of vision or sudden loss of vision or distorted vision while taking tadalafil, they should stop taking Tadalafil APTEO MED and contact their doctor immediately.
In some patients taking tadalafil, a worsening or sudden loss of hearing has been observed. Although it is not known if this event is directly related to the use of tadalafil, if the patient experiences a worsening or sudden loss of hearing, they should stop taking Tadalafil APTEO MED and contact their doctor immediately.
Tadalafil APTEO MED should not be taken with other oral or topical medicines used to treat erectile dysfunction.
Tadalafil APTEO MED should not be taken with pulmonary arterial hypertension therapies (PAH) using sildenafil or other PDE5 inhibitors.
For 48 hours after taking Tadalafil APTEO MED, the patient should not take medicines containing sildenafil used to treat erectile dysfunction or pulmonary hypertension.
Tadalafil APTEO MED should not be taken if erectile dysfunction has not been diagnosed.
Tadalafil APTEO MED is not intended for use in women.
Tadalafil APTEO MED is not intended for use in children and adolescents under 18 years of age.
Before taking Tadalafil APTEO MED, the patient should use the diagnostic tool (questionnaire). In case of any doubts, they should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Tadalafil APTEO MED should not be taken if the patient is taking nitrates.
Tadalafil APTEO MED may affect the action of some medicines or other medicines may affect the action of Tadalafil APTEO MED.
The patient should tell their doctor or pharmacist if they are taking any of the following medicines:
In some patients who take blood pressure-lowering medicines, a decrease in blood pressure may occur, especially when standing up or sitting down quickly. If the patient experiences symptoms of low blood pressure (dizziness, fainting, feeling of impending faint), they should lie down or sit down and wait for the symptoms to pass, drinking water may also help, as well as getting some fresh air, tensing abdominal muscles, or crossing legs. The patient should avoid standing up or sitting down quickly.
Information on the effect of alcohol is given in section 3. Grapefruit juice may affect the efficacy of Tadalafil APTEO MED, and therefore, it should be consumed with caution. For more information, the patient should consult their doctor or pharmacist.
When tadalafil was administered to dogs, a decrease in sperm production in the testes was observed. A decrease in sperm count has been observed in some men. It is unlikely to lead to infertility.
In some men taking tadalafil during clinical trials, dizziness was reported, so the patient should be aware of their reaction to the tablets before driving or operating machinery.
If the patient has been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
This medicine should always be taken exactly as described in this patient leaflet or as directed by the doctor or pharmacist. If the patient is unsure, they should consult their doctor or pharmacist.
Tadalafil APTEO MED tablets are intended for oral use only in men.
The tablets should be swallowed whole with a small amount of water. The tablets can be taken with or without food.
Recommended doseis one 10 mg tablet, taken before planned sexual activity. If the patient feels that the effect of Tadalafil APTEO MED is too strong or too weak, they should consult their doctor or pharmacist. The doctor may recommend a different dosing regimen after consultation. Tadalafil APTEO MED tablets are intended for oral use.
The tablet can be taken at least 30 minutes before planned sexual activity.
Tadalafil APTEO MED may be effective for up to 36 hours after taking the tablet.
Tadalafil APTEO MED is intended for use before planned sexual activity.
The medicine should be used as needed. Do not use more than once a week. Do not take more than one tablet.
Tadalafil APTEO MED should not be taken with other oral or topical medicines used to treat erectile dysfunction.
Tadalafil APTEO MED should not be taken with pulmonary arterial hypertension therapies (PAH) using sildenafil or other PDE5 inhibitors.
For 48 hours after taking Tadalafil APTEO MED, the patient should not take medicines containing sildenafil used to treat erectile dysfunction or pulmonary hypertension.
Tadalafil APTEO MED should not be taken if erectile dysfunction has not been diagnosed.
It is important to be aware that Tadalafil APTEO MED does not work in the absence of sexual stimulation. The patient and his partner should arrange foreplay, just as if the patient were not taking erectile dysfunction medication.
Consuming alcohol may cause a temporary decrease in blood pressure. If the patient has taken Tadalafil APTEO MED or plans to take it, they should not consume large amounts of alcohol (blood alcohol concentration 0.08% or higher), as this may increase the risk of dizziness when standing up.
The patient should inform their doctor. Adverse reactions described in section 4 may occur. If the patient has any further doubts about the use of this medicine, they should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. These effects are usually mild or moderate.
Other reported side effects:
Common(may affect up to 1 in 10 patients)
Uncommon(may affect up to 1 in 100 patients)
Rare(may affect up to 1 in 1,000 patients)
Heart attack and stroke have been rarely reported in men taking tadalafil. Most of them had heart problems before starting to take this medicine.
There have been reports of rare cases of partial, transient, or permanent loss of vision or loss of vision in one or both eyes.
In men taking tadalafil, several additional rare side effects have been reported, which were not observed during clinical trials. These include:
Side effects such as dizziness and diarrhea have been reported more frequently in men over 75 years of age taking tadalafil. Diarrhea has been reported more frequently in men over 65 years of age taking tadalafil.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after "EXP".
The expiry date refers to the last day of the month.
Store in a temperature below 30°C.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Yellow, biconvex, film-coated tablets in the shape of an almond, with the inscription "L 63" on one side and smooth on the other ( dimensions 10.1 mm ± 0.3 mm x 6.1 mm ± 0.3 mm).
Available pack sizes: 2 and 4 tablets.
Not all pack sizes may be marketed.
Synoptis Pharma Sp. z o.o.
ul. Krakowiaków 65
02-255 Warsaw
tel.: 22 32 16 240
Synoptis Industrial Sp. z o.o.
ul. Rabowicka 15
62-020 Swarzędz
Date of last revision of the leaflet:April 2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.